Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Peterson LS, Nelson AM, Su WPD. Classification of morphea (localized scleroderma). Mayo Clin Proc1995;70:1068–76.
Murray KJ, Laxer RM. Scleroderma in children and adolescents. Rheum Dis Clin North Am2002;28:603–24.
Uziel Y, Krafchik BR, Silverman ED, Thorner PS, Laxer RM. Localized scleroderma in childhood: a report of 30 cases. Semin Arthritis Rheum1994;23:328–40.
Vancheeswaran R, Black CM, David J et al. Childhood onset scleroderma: is it different from adult onset disease. Arthritis Rheum1996;39:1041–49.
Miller MT, Sloane H, Goldberg MF, Grisoland J, Frenke M, Mafee M. Progressive hemifacial atrophy. J Pediatr Ophthalmol Strabismus1987;24:27–36.
Marzano AV, Menni S, Parodi A et al. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol2003;13:171–6.
Bodemer C, Belon M, Hamel-Teillac D et al. Scleroderma in children: a retrospective study of 70 cases. Ann Dermatol Venereol1999;126:691–4.
Christianson HB, Dorsey CS, Kierland RR, O’Leary PA. Localized scleroderma: a clinical study of two-hundred and thirty-five cases. Arch Dermatol1956;74:629–39.
Blaszczyk M, Krysicka C, Jablonska S. Childhood scleroderma and its peculiarities. Cutis1996;58:141–52.
Jablonska S, Blaszczyk M, Rosinska D. Progressive facial hemiatrophy and scleroderma en coup de sabre. Clinical presentation and course as related to the onset in early childhood and young adults. Arch Argent Dermatol1998;48:125–8.
Blaszczyk M, Krolicki L, Krasu M, Glinska O, Jablonska S. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol2003;30:1997–2004.
Segal P, Jablonska S, Mrzyglod S. Ocular changes in linear scleroderma Am J Ophthalmol1961;51:807–13.
Muchnick RS, Sherrell JA, Rees DT. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmol1979;88:889–97.
Rosenberg AM, Uziel Y, Krafchik BR et al. Antinuclear antibodies in children with localized scleroderma. J Rheumatol1994;22:2337–43.
Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y. Antinuclear antibodies in localized scleroderma. Arthritis Rheum1983;26:612–6.
Garcia-De La Torre I, Castello-Sendra J, Esgleyes-Ribot T, Martinez-Bonilla G, Guerrerosantos J, Fitzler MJ. Autoantibodies in Parry-Romberg syndrome: a serologic study of 14 patients. J Rheumatol1995;22:73–77.
Orozco-Covarrubias L, Guzman-Meza A, Ridaura-Sanz C, Carrasco Daza D, Sosa-de-Martinez C, Ruiz-Maldonado R. Scleroderma ‘en coup de sabre’ and progressive facial hemiatrophy. Is it possible to differentiate them? J Eur Acad Dermatol Venereol2002;16:361–6.
Pensler JM, Murphy GF, Mulliken JB. Clinical and ultrastructural studies of Romberg's hemifacial atrophy. Plast Reconstr Surg1990;85:669–74.
Blaszczyk M, Jablonska S. Linear scleroderma en coup de sabre. Relationship with progressive facial hemiatrophy (PFH). Adv Exp Med Biol1999;455:101–4.
Winkelmann RK. Localized cutaneous scleroderma. Semin Dermatol1985;4:90–103.
Wadud MA, Bose BK, Al Nasir T. Familial localized scleroderma from Bangladesh: two case reports. Bangladesh Med Res Counc Bull1989;15:15–9.
Kass H, Hanson V, Patrick J, Centeno LM, Moore ME. Scleroderma in childhood. J Pediatr1966;68:243–56.
Ree RB, Bennett J. Localized scleroderma in father and daughter. Arch Dermatol1953;68:360–1.
De Keyser F, Peene I, Joos R, Naeyaert JM, Messiaen L, Veys EM. Occurrence of scleroderma in monozygotic twins. J Rheumatol2000;27:2267–9.
Shelkovitz-Shiloh I, Ehrenfeld M, Schewch-Millet M, Feinstein A. Coexistence of family systemic lupus erythematosus and localized scleroderma. Int J Dermatol1992;31:819–20.
Mackel SE, Kozin F, Ryan LM, Sheth KJ, Jordon RE. Concurrent linear scleroderma and systemic lupus erythematosus: a report of two cases. J Invest Dermatol1979;73:368–72.
Mork NJ. Clinical and histopathologic morphea with immunological evidence of lupus erythematosus: a case report. Acta Derm Venereol1981;61:367–8.
Becker KG, Simon RM, Bailey-Wilson JE et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA1998;95:9979–84.
Falanga V, Medsger TA, Reichlin M, Rodnan GP. Linear scleroderma: clinical spectrum, prognosis and laboratory abnormalities. Ann Intern Med1986;104:849–57.
Blaszczyk M, Jarzabek-Chorleska M, Jablonska S. Relationship between cutaneous and systemic scleroderma. Are immunopathological studies helpful in evaluating transition of cutaneous to systemic scleroderma? Przegl Dermatol2000;2:119–25.
Rondinone R, Germino M, Sartori E et al. Autoimmune disorders in localized scleroderma. Arch Dermatol Res1990;282:477–9.
Ruffatti A, Peserico A, Glorioso S et al. Anticentromere antibody in localized scleroderma. J Am Acad Dermatol1986;15:637–42.
Jablonska S, Chorzelski TP, Blaszczyk M. Clinical relevance of immunologic findings in scleroderma. Clin Dermatol1993;10:407–21.
Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol1998;39:220–5.
Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr2000;136:91–5.
Walsh J, Martini G, Murray KJ, Woo P, Black CM. Evaluation and treatment of childhood onset localized scleroderma. Arthritis Rheum1999;42:S231.